Drug profile

The FDA adverse-event record for Oral Bordetella Canine - 1081.01

145 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Oral Bordetella Canine - 1081.01. See the species affected, top reactions, and outcomes below.

145
adverse-event reports
11.0%
death-coded share
Dog
most-reported species
52
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
145
Total Reports
16
Deaths Reported
11.0%
Death Rate

Active Ingredients

Oral Bordetella Canine - 1081.01

Administration Routes

OralUnknownParenteral

Species Affected

Dog 145

Most Affected Breeds

Retriever - Golden 19
Retriever - Labrador 8
Poodle - Miniature 7
Chihuahua 6
Maltese 6
Bulldog - French 6
Pit Bull 5
Shih Tzu 5
Shepherd Dog - Australian 5
Poodle - Standard 4

Most Reported Reactions

Vomiting 52
Diarrhoea 27
Lethargy (see also Central nervous system depression in 'Neurological') 20
Lethargy (see also Central nervous system depression in Neurological) 17
Leucocytosis NOS 11
Neutrophilia 11
Anorexia 11
Other abnormal test result NOS 11
Cough 10
Death 10
Lack of efficacy (bacteria) - Bordetella 10
Dehydration 9

Outcome Breakdown

Recovered/Normal
54 (36.7%)
Outcome Unknown
48 (32.7%)
Ongoing
27 (18.4%)
Euthanized
9 (6.1%)
Died
9 (6.1%)

Oral Bordetella Canine - 1081.01 Adverse Event Insights

145 reports name Oral Bordetella Canine - 1081.01; 16 recorded a death outcome (11.0% of reported events, not a population-level mortality rate). Active ingredient: Oral Bordetella Canine - 1081.01. Administration routes: Oral, Unknown, Parenteral.

By species: Dog (145 reports). By breed: Retriever - Golden (19), Retriever - Labrador (8), Poodle - Miniature (7).

Leading clinical signs: Vomiting (52), Diarrhoea (27), Lethargy (see also Central nervous system depression in 'Neurological') (20), Lethargy (see also Central nervous system depression in Neurological) (17). Outcome, 147 coded reports: Recovered/Normal leads at 36.7%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.